Jefferson University Hospitals

Provider Profile

Takami Sato, MD, PhD

Jefferson University Physician

Academic Title: Professor
Director, Metastatic Uveal Melanoma Program

Specialties
Medical Oncology
Medical Oncology - Uveal Melanoma

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
925 Chestnut Street
Suite 320A
Philadelphia PA 19107
Phone: (215) 955-8874
Fax: (215) 955-2340
Philadelphia
Bodine Center
111 S. 11th Street
Philadelphia PA 19107
Phone: (215) 503-3158
Fax: (215) 955-9600

Medical Services

Board Certifications

  • Pediatrics

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Awards and Honors

Best Doctors in America 2011,2010,2009,2008,2007,2006,2005

America's Top Oncologists 2007

Notes

Dr. Sato also specializes in Cancer Immunotherapy.

Education

  • Jichi Medical University, Japan, Medical School

Residency

  • Oita Prefectural Hospital, Japan

Fellowship

  • Jichi Medical University, Japan

Recent Publications

Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls

PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma

Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases

Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis

Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer

Co-Targeting HGF/cMET Signaling with MEK Inhibitors in metastatic uveal melanoma

Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma

Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from ocular melanoma

Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment

Immune check point inhibitors combination in melanoma: Worth the toxicity?

Autologous melanoma cell vaccine using monocyte-derived dendritic cells (NBS20/eltrapuldencel-T)

Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization

Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells

Successes and setbacks of early investigational drugs for melanoma

Paracrine effect of NRG1 and HGF drives resistance to MEK inhibitors in metastatic uveal melanoma

Biology of advanced uveal melanoma and next steps for clinical therapeutics

Uveal melanoma metastatic to the liver: Chemoembolization with 1,3-bis-(2-chloroethyl)-1-nitrosourea

Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases